All lobbying filings

IPOLICY SOLUTIONS

Lobbying for ASSOCIATION FOR MOLECULAR PATHOLOGY · A medical subspecialty professional society

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Maryland · House · Senate · $70,500.00 income · posted Apr 11, 2025

Official filing document

Bills named in this filing 3

HR 1463
To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administrat…
HR 2471
Right Drug Dose Now Act of 2025
SJRES 82
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule …

Lobbying activity 4

Medical/Disease Research/Clinical Labs

No bill #: legislation to clarify CLIA FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests" HR 1463: Freedom for Laboratory Innovation and Testing Act

No bill #: Patent Eligibility Restoration Act

Budget/Appropriations

No bill number: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

Health Issues

HR 2471: Right Drug Dose Now Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.